Francesco Ferraù

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 88 citations · Full text

Medicine, Endocrinology, Oncology +11

Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial

Livia S. A. Augustin, Massimo Libra, Anna Crispo et al. · BMC Cancer · 2017 · 44 citations · Full text

Agriculture, Nutrition, Oncology +17

Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22)

Lucia Musacchio, Daniela Califano, Michele Bartoletti et al. · British Journal of Cancer · 2022 · 26 citations · Full text

Medicine, Gynecology, Oncology +16

Safety of Long-Term Administration of Bisphosphonates in Elderly Cancer Patients

Paolo Tralongo, Lazzaro Repetto, Anna Di Mari et al. · Oncology · 2004 · 25 citations

Medicine, Oncology, Pharmacology +17